Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
A21010 HRP, Goat Anti-Mouse IgG The APC10 subunit of the anaphase-promoting complex/cyclosome orchestrates NLRP3 inflammasome activation during the cell cycle(A21010-3) 3 FEBS Lett
A22120 FITC, Goat Anti-Rabbit IgG The APC10 subunit of the anaphase-promoting complex/cyclosome orchestrates NLRP3 inflammasome activation during the cell cycle(A22120-3) 3 FEBS Lett
A22220 Cy3, Goat Anti-Rabbit IgG The APC10 subunit of the anaphase-promoting complex/cyclosome orchestrates NLRP3 inflammasome activation during the cell cycle(A22220-3) 3 FEBS Lett
BMU101 The Artemisia argyi oil reduces high-fat diet-induced obesity by enhancing thermogenesis in brown adipose tissue(BMU101-7.8) 7.8 British Journal of Pharmacology 
KTE6027 EliKine™ Human MMP-9 ELISA Kit The association between APO-E genotype and inflammation and the risk of premature CHD in smokers versus non-smokers(KTE6027-2) 2 Journal of Applied Pharmaceutical Science
KTP3001 ExKine™ Nuclear and Cytoplasmic Protein Extraction Kit The autophagic regulation of rosiglitazone-promoted adipocyte browning.(KTP3001-4) 4 Frontiers in Pharmacology
A25012 IPKine™ HRP, Goat Anti-Mouse IgG LCS The blue light receptor CRY1 interacts with GID1 and DELLA proteins to repress gibberellin signaling and plant growth(A25012-24.1) 24.1 researchsquare
KTD3001 Protein Quantification Kit (BCA Assay) The biological effects of oral radioiodine administration on male rats (Rattus norvegicus): DNA damage and apoptosis.(KTD3001-1.6) 1.6  Journal of Radioanalytical and Nuclear Chemistry 
A21010 HRP, Goat Anti-Mouse IgG The CCCH-type zinc finger antiviral protein relieves immunosuppression of T cells induced by avian leukosis virus subgroup J via the NLP–PKC-δ–NFAT pathway(A21010-3.8) 3.8 Molecular Neurobiology
A21020 HRP, Goat Anti-Rabbit IgG The CCCH-type zinc finger antiviral protein relieves immunosuppression of T cells induced by avian leukosis virus subgroup J via the NLP–PKC-δ–NFAT pathway(A21020-3.8) 3.8 CANCER IMMUNOL IMMUN